首页|某院肺炎克雷伯菌临床分布特点及耐药率分析

某院肺炎克雷伯菌临床分布特点及耐药率分析

扫码查看
目的 分析我院分离的肺炎克雷伯菌(Klebsiella pneumoniae,KPN)临床分布特点及耐药情况,为医院感染控制提供参考依据.方法 收集我院2020年-2022年临床分离的KPN,分析其标本来源、科室分布、检出率,同时比较分析菌株的耐药率.结果 2020年—2022年临床分离的KPN共1 213株,其中134株为耐碳青霉烯类肺炎克雷伯菌(Carbapenem-resistant Klebsiella pneumoniae,CRKP).2020年—2022年CRKP株检出率分别为8.2%(28/342)、7.4%(30/408)和 16.4%(76/463);KPN主要分离于痰液标本,其构成比为61.1%(741/1213),其次为尿液19.5%(236/1213)、脓液6.3%(77/1213),CRKP在痰液标本中分离最多,构成比为47.8%(64/134),其次是尿液23.9%(32/134)、肺泡灌洗液14.9%(20/134);KPN检出的病区分布主要是重症医学科(ICU)、呼吸科、神经外科及肿瘤科,其构成比分别为23.0%(279/1213)、16.2%(196/1213)、13.6%(165/1213)、7.8%(95/1213).CRKP株检出较高的科室分布是ICU44.8%(60/134)、神经外科23.9%(32/134)、肿瘤科7.5%(10/134)及胸外科6.7%(9/134);碳青霉烯类敏感的肺炎克雷伯菌(Carbapenem-sensitive Klebsiella pneumoniae,CSKP)对环丙沙星及左氧氟沙星的耐药率最高,分别为41.1%和41.6%.对哌拉西林/他唑巴坦、头孢他啶在2020年—2022年中的耐药率均有逐年上升趋势(P<0.05).CRKP对亚胺培南、美罗培南、阿米卡星和复方磺胺甲恶唑的耐药率为48.5%~98.8%,无明显上升趋势(P>0.05),对其他抗菌药物的耐药率则呈逐年显著升高趋势(P<0.001);CRKP株对各类抗菌药物的耐药率均明显高于CSKP株,差异有统计学意义(P<0.001).结论 本院CRKP株检出增多,临床各科室应积极关注,防止CRKP播散流行.
Analysis of Clinical Distribution Characteristics and Antibiotics Resistance Rates of Klebsiella pneumoniae in a Hospital
Objective In order to establish a baseline for the management of nosocomial infections,it is necessary to examine the bacterial dispersion and antibiotic resistance of Klebsiella pneumoniae(KPN)that was isolated from clinical departments at Tai Zhou Hospital of Traditional Chinese Medicine.Methods Clinical specimen sources,department distribution and detection rate of KPN collected from 2020 to 2022 were analyzed.Meanwhile,the drug resistance rates of the strains in 3 years were compared and analyzed.Result A total of 1213 strains of KPN were clinically isolated from 2020 to 2022,among which 134 were carbapenem-resistant Klebsiella pneumoniae strains(CRKP).The detection rates of CRKP strains were 8.2%(28/342),7.4%(30/408)and 16.4%(76/463),respectively.KPN was mainly isolated from sputum samples with a composition ratio of 61.1%(741/1213),followed by urine 19.5%(236/1213),plus 6.3%(77/1213).CRKP strain was the most isolated in sputum samples,with a composition ratio of 47.8%(64/134),followed by urine at 23.9%(32/134),and alveolar lavage fluid at 14.9%(20/134).KPN was detected in the intensive care unit(ICU),respiratory department,neurosurgery department and oncology department,with the proportion of 23.0%(279/1213),16.2%(196/1213),13.6%(165/1213)and 7.8%(95/1213),respectively.The departments with CRKP strain were ICU 44.8%(60/134),neurosurgery 23.9%(32/134,oncology 7.5%(10/134)and thoracic surgery 6.7%(9/134).The resistance rates of carbapenem-sensitive Klebsiella pneumonia strains(CSKP)to ciprofloxacin and levofloxacin were the highest(41.1%and 41.6%).Between 2020 and 2022,there was a rise in the rates of drug resistance to ceftazidime and piperacillin/tazobactam(P<0.05).The resistance rates of CRKP to imipenem,meropenem,amikacin and cotrimoxazole were 48.5%-98.8%,with no obvious upward trend(P>0.05).The rates of resistance to other antibiotics were significantly increased(P<0.00l).In comparison to CSKP strains,CRKP strains exhibited significantly greater rates of resistance to all types of antibiotics;this difference was statistically significant(P<0.001).Conclusion In order to stop the spread of CRKP,all clinical departments should pay attention as the number of CRKP strains detected in our hospital has increased.

Klebsiella pneumoniaedrug resistance ratecarbapenem-resistancemultiple drug resistanceclinical distribution characteristicsinfection control

徐承、蒋璐、王姝

展开 >

泰州市中医院,江苏 泰州 225300

肺炎克雷伯菌 耐药率 碳青霉烯耐药 多重耐药 临床分布特征 感染控制

2024

国外医药(抗生素分册)
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

国外医药(抗生素分册)

影响因子:0.852
ISSN:1001-8751
年,卷(期):2024.45(4)